Advertisement

Advertisement

FBLG Stock Latest News

FibroBiologics files to sell up to 12.53M shares of common stock

The FlyFibroBiologics files to sell up to 12.53M shares of common stock

FibroBiologics Appoints NASA Scientist Kate Rubins to Board

PremiumCompany Announcements

FibroBiologics Appoints NASA Scientist Kate Rubins to Board

2d ago

FibroBiologics appoints Rubins to its Board of Directors

PremiumThe Fly

FibroBiologics appoints Rubins to its Board of Directors

3d ago

FibroBiologics completes manufacturing of third batch of CYWC628

PremiumThe Fly

FibroBiologics completes manufacturing of third batch of CYWC628

5d ago

FibroBiologics Secures New Private Placement Financing

PremiumCompany Announcements

FibroBiologics Secures New Private Placement Financing

12d ago

FibroBiologics announces $9M private placement priced at-the-market

PremiumThe FlyFibroBiologics announces $9M private placement priced at-the-market

16d ago

FibroBiologics Shareholders Approve New 2026 Equity Plan

Company Announcements

FibroBiologics Shareholders Approve New 2026 Equity Plan

18d ago

FibroBiologics receives notice of allowance for U.S. patent

The Fly

FibroBiologics receives notice of allowance for U.S. patent

19d ago

FibroBiologics doses first patients in CYWC628 clinical trial

PremiumThe Fly

FibroBiologics doses first patients in CYWC628 clinical trial

26d ago

FibroBiologics doses first patients in CYWC628 trial

PremiumThe Fly

FibroBiologics doses first patients in CYWC628 trial

1M ago

FibroBiologics presents preclinical data from CYPS317 program

PremiumThe Fly

FibroBiologics presents preclinical data from CYPS317 program

2M ago

FibroBiologics expands fibroblast-based platform to target Hantavirus

PremiumThe Fly

FibroBiologics expands fibroblast-based platform to target Hantavirus

2M ago

FibroBiologics Expands At-The-Market Equity Offering Capacity

PremiumCompany AnnouncementsFibroBiologics Expands At-The-Market Equity Offering Capacity

2M ago

FibroBiologics Grants Stock Options to Key Executives

Company Announcements

FibroBiologics Grants Stock Options to Key Executives

2M ago

FibroBiologics says fibroblast spheroids drive burn healing, reduce scarring

The Fly

FibroBiologics says fibroblast spheroids drive burn healing, reduce scarring

2M ago

FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial

PremiumThe Fly

FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial

2M ago

FibroBiologics downgraded to Hold from Buy at Maxim

PremiumThe Fly

FibroBiologics downgraded to Hold from Buy at Maxim

2M ago

FibroBiologics Warns of ‘Going Concern’ Risk as Losses Mount and Funding Outlook Darkens

PremiumCompany Announcements

FibroBiologics Warns of ‘Going Concern’ Risk as Losses Mount and Funding Outlook Darkens

2M ago

FibroBiologics Launches New At-The-Market Equity Offering

PremiumCompany Announcements

FibroBiologics Launches New At-The-Market Equity Offering

2M ago

FibroBiologics reports Q1 net loss roughly ($5M)

PremiumThe FlyFibroBiologics reports Q1 net loss roughly ($5M)

2M ago

FibroBiologics Secures Nasdaq Listing Compliance, Under Monitoring

Company Announcements

FibroBiologics Secures Nasdaq Listing Compliance, Under Monitoring

3M ago

FibroBiologics announces compliance with all Nasdaq listing requirements

The Fly

FibroBiologics announces compliance with all Nasdaq listing requirements

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >